Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s10637-007-9085-0
Title: | A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells | Authors: | Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. |
Keywords: | 3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine |
Issue Date: | 2008 | Citation: | Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S. (2008). A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Investigational New Drugs 26 (2) : 169-173. ScholarBank@NUS Repository. https://doi.org/10.1007/s10637-007-9085-0 | Source Title: | Investigational New Drugs | URI: | http://scholarbank.nus.edu.sg/handle/10635/27208 | ISSN: | 01676997 | DOI: | 10.1007/s10637-007-9085-0 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
128
checked on May 17, 2022
WEB OF SCIENCETM
Citations
119
checked on May 17, 2022
Page view(s)
355
checked on May 12, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.